Det aktive stof i Humalog, insulin lispro, fremstilles ved hjælp af en metode, der kaldes 'rekombinant DNA- teknologi'.
The active ingredient of Humalog, insulin lispro, is produced by a method known as ‘ recombinant DNA technology’.